Similarly, in vivo experiments have demonstrated that BAM15@BSA NPs, a functionalized drug-albumin nanocomposite prepared by co-assembling BAM15 with bovine serum albumin, exhibit a remarkable ability to target the liver, leading to potent anti-obesity effects (49). This evidence concerns the gene ALB and obesity disorder.